KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Inventory Average (2022 - 2025)

Historic Inventory Average for Novavax (NVAX) over the last 5 years, with Q3 2025 value amounting to $11.9 million.

  • Novavax's Inventory Average rose 3335.77% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 3335.77%. This contributed to the annual value of $25.2 million for FY2024, which is 3563.96% down from last year.
  • Latest data reveals that Novavax reported Inventory Average of $11.9 million as of Q3 2025, which was up 3335.77% from $10.3 million recorded in Q2 2025.
  • Novavax's 5-year Inventory Average high stood at $181.5 million for Q2 2022, and its period low was $8.7 million during Q4 2024.
  • For the 4-year period, Novavax's Inventory Average averaged around $48.3 million, with its median value being $28.8 million (2023).
  • Per our database at Business Quant, Novavax's Inventory Average tumbled by 8437.66% in 2024 and then skyrocketed by 3335.77% in 2025.
  • Novavax's Inventory Average (Quarter) stood at $59.6 million in 2022, then dropped by 6.57% to $55.6 million in 2023, then tumbled by 84.38% to $8.7 million in 2024, then surged by 36.6% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $10.3 million for Q2 2025, and $9.5 million during Q1 2025.